Title |
Palmitoyl:protein thioesterase (PPT1) inhibitors can act as pharmacological chaperones in infantile Batten disease
|
---|---|
Published in |
Biochemical & Biophysical Research Communications, March 2010
|
DOI | 10.1016/j.bbrc.2010.03.137 |
Pubmed ID | |
Authors |
Glyn Dawson, Christina Schroeder, Philip E. Dawson |
Abstract |
Competitive inhibitors of lysosomal hydrolases (pharmacological chaperones) have been used to treat some lysosomal storage diseases which result from mis-sense mutations and mis-folded protein but have not been tried in Batten disease, for which there is no current therapy. We synthesized a large number of novel, non-hydrolyzable competitive inhibitors of palmitoyl:protein thioesterase (PPT1) and showed that some could act as chemical chaperones. One inhibitor (CS38: betaAGDap(Pal)VKIKK) was taken up by lymphoblasts from patients with mutations leading to the T75P/R151X substitutions and enhanced PPT1 activity 2-fold. A similar 2-fold stimulation with another inhibitor (AcGDap(Palm)GG(R)(7)) was observed in patients with a G108R amino acid substitution in PPT1. Residual PPT1 activity in both was thermally unstable at pH 7.4 (but not at 4.7) consistent with a mis-folded, unstable PPT1 degraded by the ER stress response. Patients with null mutations did not respond to the pharmacological chaperones. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
Germany | 1 | 2% |
Unknown | 41 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 23% |
Researcher | 10 | 23% |
Student > Master | 6 | 14% |
Professor > Associate Professor | 3 | 7% |
Student > Bachelor | 2 | 5% |
Other | 6 | 14% |
Unknown | 6 | 14% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 10 | 23% |
Biochemistry, Genetics and Molecular Biology | 8 | 19% |
Chemistry | 4 | 9% |
Medicine and Dentistry | 3 | 7% |
Neuroscience | 3 | 7% |
Other | 6 | 14% |
Unknown | 9 | 21% |